Patents Assigned to Mycogen Corporation
  • Patent number: 5186934
    Abstract: A novel B.t. gene encoding a toxin which is toxic to coleopteran insects has been cloned from a coleopteran-active B. thurningiensis microbe. The DNA encoding the B.t. toxin can be used to transform various prokaryotic and eukaryotic microbes to express the B.t. toxin. These recombinant microbes can be used to control coleopteran insects in various environments.
    Type: Grant
    Filed: June 12, 1991
    Date of Patent: February 16, 1993
    Assignee: Mycogen Corporation
    Inventors: Kenneth E. Narva, George E. Schwab, Gregory A. Bradfisch
  • Patent number: 5185148
    Abstract: Certain isolates of Bacillus thuringiensis (B.t.) have been found to have activity against Scarab pests. These isolates are designated B.t. PS86B1, B.t. PS43F and B.t. PS50C. These isolates, or transformed hosts containing the gene expressing a Scarab-active toxin obtained from the isolates, can be used to control Scarab-active pests, e.g., Masked Chafer, Cyclocephala sp., June Beetle, Cotinis sp., Northern Masked Chafer, Cyclocephala borealis, Japanese Beetle, Popillia japonica, and Pasedena Masked Chafer, Cyclocephala pasadenae, in various environments.
    Type: Grant
    Filed: January 30, 1992
    Date of Patent: February 9, 1993
    Assignee: Mycogen Corporation
    Inventor: Tracy E. Michaels
  • Patent number: 5169629
    Abstract: A novel B.t. isolate with activity against lepidopteran insects is disclosed. This isolate is highly active agaist the beet armyworm. A gene from this isolate has been cloned. The DNA encoding the B.t. toxin can be used to transform various prokaryotic and eukaryotic microbes to express the B.t. toxin. These recombinant microbes can be used to control lepidopteran insects in various environments.
    Type: Grant
    Filed: November 1, 1988
    Date of Patent: December 8, 1992
    Assignee: Mycogen Corporation
    Inventors: Jewel Payne, August J. Sick, Mark Thompson
  • Patent number: 5169760
    Abstract: The invention is a process for controlling the expression of heterologous genes from lac-operated promoters by removing the CAP binding site and lac promoter from the lac operon. Illustrated is the fusion of the lacZ, Y, and A genes of the lac operon to the 3' end of the lacI structural gene. This elimination of the natural regulatory elements of the lac operon results, advantageously, in the production of lac operon gene products in a constitutive mode from the lacI promoter.
    Type: Grant
    Filed: July 27, 1989
    Date of Patent: December 8, 1992
    Assignee: Mycogen Corporation
    Inventor: Edward R. Wilcox
  • Patent number: 5164180
    Abstract: Novel Bacillus thuringiensis genes encoding toxins which are active against lepidopteran insects have been cloned from novel lepidopteran-active B. thuringiensis microbes. The DNA encoding the B. thuringiensis toxins can be used to transform various prokaryotic and eukaryotic microbes to express the B. thuringiensis toxins. These recombinant microbes can be used to control lepidopteran insects in various environments.
    Type: Grant
    Filed: December 14, 1989
    Date of Patent: November 17, 1992
    Assignee: Mycogen Corporation
    Inventors: Jewel Payne, August J. Sick
  • Patent number: 5151363
    Abstract: The invention concerns novel isolates of Bacillus thuringiensis (B.t.) which contain a toxin(s) which is active against nematodes. This B.t. toxin(s) or B.t. isolate(s) can be used to treat animals and plants hosting susceptible nematodes.
    Type: Grant
    Filed: July 27, 1990
    Date of Patent: September 29, 1992
    Assignee: Mycogen Corporation
    Inventor: Jewel M. Payne
  • Patent number: 5135867
    Abstract: A novel B.t. isolate with activity against lepidopteran insects is disclosed. This isolate is highly active against the beet armyworm. A gene from this isolate has been cloned. The DNA encoding the B.t. toxin can be used to transform various prokaryotic and eukaryotic microbes to express the B.t. toxin. These recombinant microbes can be used to control lepidopteran insects in various environments.
    Type: Grant
    Filed: November 16, 1990
    Date of Patent: August 4, 1992
    Assignee: Mycogen Corporation
    Inventors: Jewel Payne, August J. Sick, Mark Thompson
  • Patent number: 5133962
    Abstract: A novel B.t. toxin gene encoding a protein toxic to coleopteran insects has been cloned from a novel coleopteran-active B. thuringiensis microbe. The DNA encoding the B.t. toxin can be used to transform various prokaryotic and eukaryotic microbes to express the B.t. toxin. These recombinant microbes can be used to control coleopteran insects in various environments.
    Type: Grant
    Filed: November 9, 1989
    Date of Patent: July 28, 1992
    Assignee: Mycogen Corporation
    Inventors: August J. Sick, Thomas E. Gilroy
  • Patent number: 5128130
    Abstract: A novel hybrid B.t. toxin gene toxic to lepidopteran insects has been cloned. The DNA encoding the B.t. toxin can be used to transform various prokaryotic and eukaryotic microbes to express the B.t. toxin. These recombinant microbes can be used to control lepidopteran insects in various environments.
    Type: Grant
    Filed: August 14, 1990
    Date of Patent: July 7, 1992
    Assignee: Mycogen Corporation
    Inventors: Thomas E. Gilroy, Edward R. Wilcox
  • Patent number: 5126133
    Abstract: Novel Bacillus thuringiensis genes encoding toxins which are active against lepidopteran insects have been cloned from novel lepidopteran-active B. thuringiensis microbes. The DNA encoding the B. thuringiensis toxins can be used to transform various prokaryotic and eukaryotic microbes to express the B. thuringiensis toxins. These recombinant microbes can be used to control lepidopteran insects in various environments.
    Type: Grant
    Filed: June 27, 1989
    Date of Patent: June 30, 1992
    Assignee: Mycogen Corporation
    Inventors: Jewel Payne, August J. Sick
  • Patent number: 5106620
    Abstract: The subject invention concerns the use of a novel and useful bioinsecticide against the lesser mealworm (Alphitobius diaperinus). The lesser mealworm is a devastating pest in the poultry industry. The bioinsecticide of the subject invention is a novel B. thuringiensis microbe referred to as B.t. PS122D3, or mutants thereof. The spores or toxin crystals of this microbe are useful to control the lesser mealworm in various environments.
    Type: Grant
    Filed: September 11, 1990
    Date of Patent: April 21, 1992
    Assignee: Mycogen Corporation
    Inventors: Leslie A. Hickle, Gregory A. Bradfisch, Jewel M. Payne
  • Patent number: 5104974
    Abstract: A novel B.t. toxin gene encoding a protein toxic to coleopteran insects has been cloned from a novel coleopteran-active B. thuringiensis microbe. The DNA encoding the B.t. toxin can be used to transform various prokaryotic and eukaryotic microbes to express the B.t. toxin. These recombinant microbes can be used to control coleopteran insects in various environments.
    Type: Grant
    Filed: November 9, 1989
    Date of Patent: April 14, 1992
    Assignee: Mycogen Corporation
    Inventors: August J. Sick, Thomas E. Gilroy
  • Patent number: 5100665
    Abstract: The subject invention concerns the use of a novel and useful bioinsecticide against the lesser mealworm (Alphitobius diaperinus). The lesser mealworm is a devastating pest in the poultry industry. The bioinsecticide of the subject invention is a novel B. thuringiensis microbe referred to as B.t. PS86B1, or mutants thereof. The spores or toxin crystals of this microbe are useful to control the lesser mealworm in various environments.
    Type: Grant
    Filed: September 11, 1990
    Date of Patent: March 31, 1992
    Assignee: Mycogen Corporation
    Inventors: Leslie A. Hickle, Gregory A. Bradfisch, Jewel M. Payne
  • Patent number: 5098705
    Abstract: The subject invention concerns the use of a novel and useful bioinsecticide against the lesser mealworm (Alphitobius diaperinus). The lesser mealworm is a devastating pest in the poultry industry. The bioinsecticide of the subject invention is a novel B. thuringiensis microbe referred to as B.t. PS40D1, or mutants thereof. The spores or toxin crystals of this microbe are useful to control the lesser mealworm in various environments.
    Type: Grant
    Filed: September 11, 1990
    Date of Patent: March 24, 1992
    Assignee: Mycogen Corporation
    Inventors: Leslie A. Hickle, Gregory A. Bradfisch, Jewel M. Payne
  • Patent number: 5093119
    Abstract: The subject invention concerns the use of a novel and useful bioinsecticide against the lesser mealworm (Alphitobius diaperinus). The lesser mealworm is a devastating pest in the poultry industry. The bioinsecticide of the subject invention is a novel B. thuringiensis microbe referred to as B.t. MT 104, or mutants thereof. The spores or toxin crystals of this microbe are useful to control the lesser mealworm in various environments.
    Type: Grant
    Filed: September 11, 1990
    Date of Patent: March 3, 1992
    Assignee: Mycogen Corporation
    Inventors: Leslie A. Hickle, Gregory A. Bradfisch, Jewel M. Payne
  • Patent number: 5093120
    Abstract: The invention concerns novel isolates of Bacillus thuringiensis (B.t.) which contains a toxin(s) which is active against adult nematode worms and larvae. This B.t. toxin(s) can be used to treat animals and plants hosting susceptible nematodes.
    Type: Grant
    Filed: May 24, 1990
    Date of Patent: March 3, 1992
    Assignee: Mycogen Corporation
    Inventors: David L. Edwards, Jewel Payne, George G. Soares
  • Patent number: 5064648
    Abstract: The subject invention concerns the use of a novel and useful bioinsecticide against the lesser mealworm (Alphitobius diaperinus). The lesser mealworm is a devasting pest in the poultry industry. The bioinsecticide of the subject invention is a novel B. thuringiensis microbe referred to a B.t. PS43F, or mutants thereof. The spores or toxin crystals of this microbe are useful to control the lesser mealworm in various environments.
    Type: Grant
    Filed: September 11, 1990
    Date of Patent: November 12, 1991
    Assignee: Mycogen Corporation
    Inventors: Leslie A. Hickle, Gregory A. Bradfisch, August J. Sick
  • Patent number: 5055294
    Abstract: A novel hybrid B.t. toxin gene toxic to lepidopteran insects has been cloned. The DNA encoding the B.t. toxin can be used to transform various prokaryotic and eukaryotic microbes to express the B.t. toxin. These recombinant microbes can be used to control lepidopteran insects in various environments.
    Type: Grant
    Filed: March 3, 1988
    Date of Patent: October 8, 1991
    Assignee: Mycogen Corporation
    Inventor: Thomas E. Gilroy
  • Patent number: 5045469
    Abstract: A novel B.t. toxin gene toxic to lepidopteran insects has been cloned from a novel lepidopteran-active B. thuringiensis microbe. The DNA encoding the B.t. toxin can be used to transform various prokaryotic and eukaryotic microbes to express the B.t. toxin. These recombinant microbes can be used to control lepidopteran insects in various environments.
    Type: Grant
    Filed: October 27, 1988
    Date of Patent: September 3, 1991
    Assignee: Mycogen Corporation
    Inventors: Jewel Payne, August J. Sick
  • Patent number: 5039523
    Abstract: A novel B.t. toxin gene encoding a protein toxic to lepidopteran insects has been cloned from a novel lepidopteran-active B. thuringiensis microbe. The DNA encoding the B.t. toxin can be used to transform various prokaryotic and eukaryotic microbes to express the B.t. toxin. These recombinant microbes can be used to control lepidopteran insects in various environments.
    Type: Grant
    Filed: November 13, 1990
    Date of Patent: August 13, 1991
    Assignee: Mycogen Corporation
    Inventors: Jewel Payne, August J. Sick